Proteome Sciences

1. 16 Sep 26
   Appointment of Non-Executive Director

   Proteome Sciences plc (AIM:PRM) is pleased to announce the appointment of Helen Spice FCA as an independent non-executive director of the Company, with immediate effect.

   RNS 9774113 ↗
2. 16 Sep 26
   Interim Results H1 2026

   Interim results for the six months ended 30 June 2026

   RNS 9773902 ↗
3. 15 Sep 26
   Further GCLP Chemoproteomics contract secured

   As initially announced in June this year, Proteome Sciences plc (AIM:PRM) is pleased to now confirm that the Company has secured the expected significant clinical contract for its chemoproteomics platform.

   RNS 9772710 ↗
4. 22 Jun 26
   Target engagement/chemoproteomics contract

   Proteome Sciences plc (AIM:PRM) is pleased to announce that the Company has secured a further significant clinical contract connected to its target engagement/chemoproteomics platform.

   RNS 9628650 ↗
5. 01 Jun 26
   Directorate Change

   The directors of Proteome Sciences plc announce that Dr Ian Pike has decided to step down from his executive role as Chief Scientific Officer with effect from 31 May 2026.

   RNS 9593276 ↗
6. 14 May 26
   Annual General Meeting Statement

   At the Company's Annual General Meeting ("AGM") being held today at 12.00 noon, the Chairman, Christopher Pearce, made the following statement:

   RNS 9568939 ↗
7. 15 Apr 26
   Final Results

   Final results for the year ended 31 December 2025

   RNS 9520298 ↗
8. 28 Jan 26
   Result of Oversubscribed Retail Offer

   596/2014, AS INCORPORATED INTO UK LAW BY THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("UK MAR").

   RNS 9392088 ↗
9. 26 Jan 26
   Retail Offer to raise up to £60,000

   Proteome Sciences (AIM: PRM) is pleased to announce the launch of an offer to retail investors in the UK through BookBuild (the "Retail Offer") of up to 3,428,571 new ordinary shares of one penny each in the capital of the Company ("Retail Offer Shares")...

   RNS 9385987 ↗
10. 26 Jan 26
    £840,000 Fundraise and Retail Offer

    This Announcement does not constitute a prospectus or offering memorandum or an offer in respect of any securities and is not intended to provide the basis for any investment decision in respect of Proteome Sciences plc or other evaluation of any...

    RNS 9385650 ↗
11. 06 Jan 26
    Two Further Substantial Contracts for PRM

    Prior to publication, the information contained within this announcement was deemed by the Company to constitute inside information as stipulated under the UK Market Abuse Regulations.

    RNS 9334949 ↗
12. 08 Dec 25
    Substantial contract for Proteome Sciences

    Prior to publication, the information contained within this announcement was deemed by the Company to constitute inside information as stipulated under the UK Market Abuse Regulations.

    RNS 9281026 ↗
13. 25 Nov 25
    Appointment of Nominated Adviser and Broker

    Proteome Sciences (AIM:PRM), is pleased to announce that SP Angel Corporate Finance LLP has been appointed as the Company's new Nominated Adviser and sole Broker with immediate effect.

    RNS 9254653 ↗

Source: Investegate RNS archive. Quotes are short extracts. Not investment advice.